EUVIMEDDescoperă EUVIMED
Crossref

Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A

Xiaoxi Liu, Jia Lai, Xiaoqin Zhang, Anguo Wu iD, Ling Zhou, Yueyue Li, Qianqian Huang, Xinwu Huang, Hua Li, Cai Lan, Jian Liu, Feihong Huang and 1 more

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8317 ↗

At a glance

Journal article in Phytotherapy Research, 2024. Written by Xiaoxi Liu and 12 co-authors. Institution: School of Pharmacy, Southwest Medical University, Luzhou, China. Major MEDLINE topics: Megakaryocytes, Thrombopoiesis, Cell Differentiation, Harmine. Cited 2 times so far (Crossref); 52 references. Funded by: National Natural Science Foundation of China, Sichuan Science and Technology Program, The Open Project Program of State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Harmine (HM), a β‐carboline alkaloid extracted from plants, is a crucial component of traditional Chinese medicine (TCM) known for its diverse pharmacological activities. Thrombocytopenia, a common and challenging hematological disorder, often coexists with serious illnesses. Previous research has shown a correlation between HM and thrombocytopenia, but the mechanism needs further elucidation. The aim of this study was to clarify the mechanisms underlying the effects of HM on thrombocytopenia and to develop new therapeutic strategies. Flow cytometry, Giemsa staining, and Phalloidin staining were used to assess HM's impact on Meg‐01 and HEL cell differentiation and maturation in vitro. A radiation‐induced thrombocytopenic mouse model was employed to evaluate HM's effect on platelet production in vivo. Network pharmacology, molecular docking, and protein blotting were utilized to investigate HM's targets and mechanisms. The results demonstrated that HM dose‐dependently promoted Meg‐01 and HEL cell differentiation and maturation in vitro and restored platelet levels in irradiated mice in vivo. Subsequently, HM was found to be involved in the biological process of platelet production by upregulating the expressions of Rac1, Cdc42, JNK, and 5‐HTR2A. Furthermore, the targeting of HM to 5‐HTR2A and its correlation with downstream Rac1/Cdc42/JNK were also confirmed. In conclusion, HM regulates megakaryocyte differentiation and thrombopoiesis through the 5‐HTR2A and Rac1/Cdc42/JNK pathways, providing a potential treatment strategy for thrombocytopenia.

Subjects

MeSH terms (MEDLINE)

MegakaryocytesThrombopoiesisCell DifferentiationHarminerac1 GTP-Binding ProteinReceptor, Serotonin, 5-HT2AAnimalsMiceHumansThrombocytopeniaMAP Kinase Signaling SystemBlood PlateletsMaleMolecular Docking Simulation

Author keywords

5‐HTR2A/Rac1/Cdc42/JNKharminemegakaryocyte differentiationradiationthrombocytopeniathrombopoiesis

Substances

Harminerac1 GTP-Binding ProteinReceptor, Serotonin, 5-HT2A

Authors and institutions

  • School of Pharmacy, Southwest Medical University, Luzhou, China.
  • School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
  • Education Ministry Key Laboratory of Medical Electrophysiology, Sichuan Key Medical Laboratory of New Drug Discovery and Druggability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation f…
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

ORCID profiles: Anguo Wu, Jianming Wu

Funding

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • The Open Project Program of State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China
  • The Open Project Program Fund of Chengdu University of Traditional Chinese Medicine State Key Laboratory of Southwestern Chinese Medicine Resources
  • The Science and Technology Planning Project of Yibin City
  • The school-level Fund of Southwest Medical University

Cite

APA

Liu, X., Lai, J., Zhang, X., Wu, A., Zhou, L., Li, Y., Huang, Q., Huang, X., Li, H., Lan, C., Liu, J., Huang, F., & Wu, J. (2024). Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A. Phytotherapy Research. https://doi.org/10.1002/ptr.8317

Vancouver

Liu X, Lai J, Zhang X, Wu A, Zhou L, Li Y, et al. Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A. Phytotherapy Research. 2024. doi:10.1002/ptr.8317

BibTeX
@article{Liu2024,
  author = {Liu, Xiaoxi and Lai, Jia and Zhang, Xiaoqin and Wu, Anguo and Zhou, Ling and Li, Yueyue and Huang, Qianqian and Huang, Xinwu and Li, Hua and Lan, Cai and Liu, Jian and Huang, Feihong and Wu, Jianming},
  title = {Harmine promotes megakaryocyte differentiation and thrombopoiesis by activating the Rac1/Cdc42/ JNK pathway through a potential target of 5‐ HTR2A},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8317}
}
Start for free →